International Biophysics' AffloVest Wins CE Mark Approval for Use in Europe and Elsewhere

Published: Nov 28, 2016

International Biophysics Corporation, a medical device manufacturer, recently announced that the company received the CE Mark and approval from Health Canada and the Australian Therapeutic Goods Administration (TGA) for its AffloVest. This means that the company will now be able to market and sell the vest in Canada, Australia, New Zealand, countries of the European Union, and others using the CE mark.

“Gaining these approvals is an exciting achievement for us. We are very happy to now be able to provide this innovative technology to patients in our neighboring Canada, as well as Australia, New Zealand and the rest of the world.

Back to news